EcoR1 Capital’s Minerva Neurosciences NERV Stock Holding History

EcoR1 Capital’s Portfolio NERV Stock Details NERV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-27,975	Closed	-$1.98M	–	45
2017 Q2	$1.98M	Buy	+27,975	New	+$1.81M	0.35%	28

Other funds holding NERV

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

HCMT

Highland Capital Management (Texas) Dallas, Texas $39M AUM

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Ascend Capital Orinda, California $1.99B AUM 10.36% 1-Year Est. Return

SFM

Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

EcoR1 Capital's NERV Position: Q3 2017 in Review

EcoR1 Capital sold out of Minerva Neurosciences (NERV) in Q3 2017, closing a stake of 27,975 shares — an estimated $1.98M sold.

EcoR1 Capital first reported a position in NERV in Q2 2017 and held it in 1 quarter. The position peaked at $1.98M in Q2 2017. 70 funds tracked by Wall St. Rank hold NERV as of Q3 2017.

EcoR1 Capital reported no remaining Minerva Neurosciences position as of Q3 2017 after selling out during the quarter.
EcoR1 Capital sold 27,975 Minerva Neurosciences shares in Q3 2017, an estimated $1.98M.
EcoR1 Capital first reported a position in Minerva Neurosciences in Q2 2017 and held it in 1 quarter.
EcoR1 Capital's Minerva Neurosciences position peaked at $1.98M in Q2 2017.
70 funds tracked by Wall St. Rank held Minerva Neurosciences as of Q3 2017.

Based on EcoR1 Capital's 13F filing for Q3 2017, filed 14 Nov 2017.